Conflicts of interests:
Kirsten Beyer reports advisory board/consulting fees or speakers bureau from Aimmune Therapeutics, Bencard, Danone/Nutricia, DBV, Hycor, Infectopharm, Mabylon, Meda Pharma/Mylan, Nestle, Novartis and ThermoFisher as well as research grants from Aimmune, ALK, Danone/Nutricia, DBV Technologies, Hipp, Hycor, Infectopharm and Novartis outside the submitted work. Birgit Kalb reports advisory board/consulting fees from Viatris. Valérie Trendelenburg received speaker’s fees from Nutricia/Danone. Friederike Bluhme, Stephanie Heller and Lara Meixner have nothing to disclose.
Financial support: This study was funded in part by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as part of the clinical research unit (CRU339): Food allergy and tolerance (FOOD@) – 409525714.